|
Volumn 3, Issue , 1998, Pages
|
Novel approaches in development for the treatment of pancreatic cancer.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
FARNESYL TRANS TRANSFERASE;
METALLOPROTEINASE;
MONOCLONAL ANTIBODY;
TRANSFERASE;
TRASTUZUMAB;
TUMOR ANTIGEN;
ADENOCARCINOMA;
ANIMAL;
DRUG ANTAGONISM;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
PANCREAS TUMOR;
REVIEW;
ADENOCARCINOMA;
ALKYL AND ARYL TRANSFERASES;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
ENZYME INHIBITORS;
FARNESYLTRANSTRANSFERASE;
HUMANS;
IMMUNOTHERAPY;
METALLOENDOPEPTIDASES;
PANCREATIC NEOPLASMS;
RECEPTOR, ERBB-2;
|
EID: 0032209246
PISSN: None
EISSN: 10934715
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (13)
|
References (45)
|